Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?

doi:10.3748/wjg.v26.i38.5896

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 38

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7654)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

485

WORD

125

HTML

4103

Figures (1-5)

281

Tables (1-2)

235

Sum=5229

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

753

Download

1672

Sum=2425

Oct 14, 2020 (publication date) through Jul 29, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Oct 14, 2020; 26(38): 5896-5910
Published online Oct 14, 2020. doi: 10.3748/wjg.v26.i38.5896

Full Size Figure Download Figure

Figure 2 Assessment of methodological quality (risk of bias) of articles identified in the systematic literature search and included in our meta-analysis.

Citation: Abdollahi M, Khalilian Ekrami N, Ghojazadeh M, Boezen HM, Somi M, Alizadeh BZ. Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations? World J Gastroenterol 2020; 26(38): 5896-5910
URL: https://www.wjgnet.com/1007-9327/full/v26/i38/5896.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i38.5896